BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2825918)

  • 1. A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity.
    Kalin NH; Shelton SE; Barksdale CM; Brownfield MS
    Brain Res; 1987 Nov; 426(2):385-91. PubMed ID: 2825918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
    Geracioti TD; Loosen PT; Orth DN
    Biol Psychiatry; 1997 Aug; 42(3):165-74. PubMed ID: 9232208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism.
    Van Wijk PA; Rijnberk A; Croughs RJ; Voorhout G; Sprang EP; Mol JA
    Endocrinology; 1992 Dec; 131(6):2659-62. PubMed ID: 1332844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation of cerebrospinal fluid immunoreactive corticotropin-releasing hormone levels in healthy volunteers.
    Kling MA; DeBellis MD; O'Rourke DK; Listwak SJ; Geracioti TD; McCutcheon IE; Kalogeras KT; Oldfield EH; Gold PW
    J Clin Endocrinol Metab; 1994 Jul; 79(1):233-9. PubMed ID: 8027234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH.
    Bagdy G; Calogero AE; Szemeredi K; Chrousos GP; Gold PW
    Regul Pept; 1990 Nov; 31(2):83-92. PubMed ID: 2176309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid and plasma corticotropin-releasing hormone in senile dementia.
    Suemaru S; Hashimoto K; Ogasa T; Hirasawa R; Makino S; Ota Z; Kageyama J; Suemaru K
    Life Sci; 1991; 48(19):1871-9. PubMed ID: 1645837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental corticotropin-releasing hormone and pituitary-adrenal function during pregnancy.
    Goland RS; Conwell IM; Warren WB; Wardlaw SL
    Neuroendocrinology; 1992 Nov; 56(5):742-9. PubMed ID: 1336818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor: a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm.
    Garrick NA; Hill JL; Szele FG; Tomai TP; Gold PW; Murphy DL
    Endocrinology; 1987 Oct; 121(4):1329-34. PubMed ID: 3498627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL; Irvine CH; Livesey JH; Donald RA
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.
    Sasaki A; Shinkawa O; Yoshinaga K
    J Clin Invest; 1989 Dec; 84(6):1997-2001. PubMed ID: 2556451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease.
    May C; Rapoport SI; Tomai TP; Chrousos GP; Gold PW
    Neurology; 1987 Mar; 37(3):535-8. PubMed ID: 3029628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm.
    Ayala AR; Pushkas J; Higley JD; Ronsaville D; Gold PW; Chrousos GP; Pacak K; Calis KA; Gerald M; Lindell S; Rice KC; Cizza G
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5729-37. PubMed ID: 15531536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.
    Barr CS; Dvoskin RL; Yuan Q; Lipsky RH; Gupte M; Hu X; Zhou Z; Schwandt ML; Lindell SG; McKee M; Becker ML; Kling MA; Gold PW; Higley D; Heilig M; Suomi SJ; Goldman D
    Arch Gen Psychiatry; 2008 Aug; 65(8):934-44. PubMed ID: 18678798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
    Wong ML; Kling MA; Munson PJ; Listwak S; Licinio J; Prolo P; Karp B; McCutcheon IE; Geracioti TD; DeBellis MD; Rice KC; Goldstein DS; Veldhuis JD; Chrousos GP; Oldfield EH; McCann SM; Gold PW
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):325-30. PubMed ID: 10618417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD; Orth DN; Ekhator NN; Blumenkopf B; Loosen PT
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1325-30. PubMed ID: 1317385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
    Wilson ME; Fisher J; Brown J
    Physiol Behav; 2005 Mar; 84(3):449-58. PubMed ID: 15763583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.